"Above all do no harm:" horizons in pediatric oncology.

doi:10.1097/00008480-199404000-00017

Back to search

Article

"Above all do no harm:" horizons in pediatric oncology.

Current opinion in pediatrics - 1 Apr 1994

Weitman S D, Winick N J, Kamen B A

Abstract excerpt

The articles selected in this review highlight some advances in the use of the "old standards" methotrexate and 6-mercaptopurine for the treatment of children with acute lymphoblastic leukemia, especially the laboratory studies, which may allow a "pharmacologic phenotyping" to identify children m...

Topics

Bone Marrow Transplantation
Child
Combined Modality Therapy
Growth Substances
Humans
Leukemia, Myeloid, Acute
Medical Oncology
Mercaptopurine
Methotrexate
Pediatrics
Phenotype
Podophyllotoxin
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Quality of Life
Recurrence
Survival Rate

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.